Daré Bioscience (DARE) Earnings Date, Estimates & Call Transcripts $2.98 +0.05 (+1.71%) Closing price 05/2/2025 04:00 PM EasternExtended Trading$2.97 -0.01 (-0.34%) As of 05/2/2025 04:08 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Daré Bioscience Earnings Summary Upcoming Earnings DateMay. 13After Market ClosesEstimatedConsensus EPS (Mar. 31) -$0.66 Actual EPS (Mar. 31) -$0.64 Beat By $0.02 Actual Revenue (Mar. 31) -$0.06MDaré Bioscience issued Q4 2024 earnings on March 31, 2025, reporting an EPS of -$0.64, which beat analysts' consensus estimates of -$0.66 by $0.02. Quarterly revenue was reported to be ($0.06) million, below the consensus estimate of $1 million. With a trailing EPS of -$0.51, Daré Bioscience's earnings are expected to decrease next year, from ($0.49) to ($1.90) per share. Q4 2024 Earnings ResourcesQ4 2024 Earnings ReportConference Call Transcript & Audio Annual Report (10-K) Press Release (8-K)SEC FilingDARE Upcoming EarningsDaré Bioscience's Q1 2025 earnings is scheduled for Tuesday, May 13, 2025, with a conference call scheduled at 4:30 PM ET. Check back for transcripts, audio, and key financial metrics as they become available.Q1 2025 Earnings ReportPowered by Get Daré Bioscience Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Daré Bioscience and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataDARE Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.DARE Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Daré Bioscience Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20252-$0.68-$0.57-$0.63Q2 20252-$0.62-$0.23-$0.43Q3 20251-$0.45-$0.45-$0.45Q4 20251-$0.21-$0.21-$0.21 Daré Bioscience Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 5/13/2025(Estimated)-------3/31/2025Q4 2024-$0.66-$0.64+$0.02-$0.64$1.00M-$0.06M8/12/2024Q2 2024-$0.57$1.52+$2.09$1.52$0.60M$0.02M5/14/2024Q1 2024-$0.72-$0.84 -$0.12-$0.07$0.52M$0.01M3/28/2024Q4 2023-$1.44-$0.72+$0.72-$0.06$2.17M$1.81M11/9/2023Q3 2023-$1.20-$1.08+$0.12-$0.09$1.20M$1.00M8/10/2023Q2 2023-$1.20-$1.20--$0.10--5/11/2023Q1 2023-$1.20-$1.08+$0.12-$0.09-- Daré Bioscience Earnings - Frequently Asked Questions When is Daré Bioscience's earnings date? Daré Bioscience has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 13th, 2025 based off last year's report dates. Learn more on DARE's earnings history. Did Daré Bioscience beat their earnings estimates last quarter? In the previous quarter, Daré Bioscience (NASDAQ:DARE) reported ($0.64) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.66) by $0.02. Learn more on analysts' earnings estimate vs. DARE's actual earnings. How can I listen to Daré Bioscience's earnings conference call? The conference call for Daré Bioscience's latest earnings report can be listened to online. Listen to Conference Call How can I read Daré Bioscience's conference call transcript? The conference call transcript for Daré Bioscience's latest earnings report can be read online. Read Transcript How can I view Daré Bioscience's earnings report? Daré Bioscience's earnings report can be found in their filing with the SEC. View SEC filing How much revenue does Daré Bioscience generate each year? Daré Bioscience (NASDAQ:DARE) has a recorded annual revenue of $9,784.00. How much profit does Daré Bioscience generate each year? Daré Bioscience (NASDAQ:DARE) has a recorded net income of -$30.16 million. DARE has generated -$0.51 earnings per share over the last four quarters. What is Daré Bioscience's EPS forecast for next year? Daré Bioscience's earnings are expected to decrease from ($0.49) per share to ($1.90) per share in the next year. More Earnings Resources from MarketBeat Related Companies VXRT Earnings Results ZNTL Earnings Results SGMT Earnings Results GNLX Earnings Results ZURA Earnings Results ATOS Earnings Results SNTI Earnings Results OPTN Earnings Results HLVX Earnings Results OCX Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Amazon Earnings: 2 Reasons to Love It, 1 Reason to Be CautiousMeta Takes A Bow With Q1 Earnings - Watch For Tariff Impact in Q2Palantir Earnings: 1 Bullish Signal and 1 Area of ConcernVisa Q2 Earnings Top Forecasts, Adds $30B Buyback PlanMicrosoft Crushes Earnings, What’s Next for MSFT Stock?Qualcomm's Earnings: 2 Reasons to Buy, 1 to Stay AwayAMD Stock Signals Strong Buy Ahead of Earnings This page (NASDAQ:DARE) was last updated on 5/4/2025 by MarketBeat.com Staff From Our PartnersThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredMost traders are panicking. We’re cashing inMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Daré Bioscience, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Daré Bioscience With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy DARE Stock Free DARE Stock Alerts